Oncotarget is a renowned scientific journal. Most medical professionals and the public refer to the various articles posted on the journal. Since 2010, when it was launched, the journal has had a positive impact in Oncology and other fields. Over the years, the journal has attracted the attention of different audiences considering that the content posted on the journal is of high quality. To this end, the management of Oncotarget saw the need to widen the scope of topics that the journal can publish. By publishing their papers with the company, authors benefit from peer-reviews and honest opinions shared by renowned scientific experts. Learn more about Oncotarget at researchgate.net
Oncotarget is an open access journal. This means that anyone with access to the internet can download the journal. The availability of different articles ensure that the authors who publish their papers with the Journal have a larger audience spread across the globe. Thousands of readers who visit the Dove website on a regular basis can access the journals.
Despite receiving many papers from different authors, Oncotarget does not reject a paper due to lack of space. This is because the journal is an electronic publication. This way, its size is not limited by size or number of papers. For authors, this means that all peer-reviewed articles can be published quickly. This information was originally mentioned on Dove Press as outlined in this link https://www.dovepress.com/call-for-papers-oncotargets-and-therapy-d65-j23
It takes three weeks for a paper to be submitted and either accepted or rejected. With traditional journals, one had to wait for months for any decision to be reached by the management and communicated to the author. The first two weeks are for peer reviewing. The editor makes his or her decision on the paper on the fourth week.
Comments from Oncotarget’s reviewers are credible and improves the quality of the final paper. Such improvements do not only focus on ensuring that the correct information is passed to the audience, but also ensuring that the author’s credibility is enhanced. Seasoned scientists, who are working in leading medical institutions, undertake the peer-review process.
Oncotarget is a peer-reviewed publication that covers different topics on oncology. The journal is published by the Impact Journals. Its editors-in-chief are Andrei Gudkov and Mikhail Blagosklonny. Oncotarget enjoys an excellent impact factor rating of over 5.000. The digital journal is published once per week. Check the journal at SCImago Journal & Country Rank.